XML 30 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest in Consolidated Subsidiaries
Balance, beginning of period (in shares) at Dec. 31, 2022   57,655          
Balance, beginning of period at Dec. 31, 2022 $ 3,003,010 $ 58 $ 847,965 $ 2,248,948 $ (118) $ (95,321) $ 1,478
Treasury stock, beginning of period (in shares) at Dec. 31, 2022         14    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Restricted stock units vested (in shares)   336          
Equity withheld for employee taxes (in shares)   (103)          
Equity withheld for employee taxes (29,301)   (29,301)        
Stock issued in connection with 2021 acquisition (in shares)   14     (14)    
Stock issued in connection with 2021 acquisition 3,000   2,882   $ 118    
Stock-based compensation expense $ 135,500   135,500        
Exercise of stock options (in shares) 397 398          
Exercise of stock options $ 15,513   15,513        
Issuance of common stock from employee stock purchase plan (in shares)   173          
Issuance of common stock from employee stock purchase plan 36,255   36,255        
Repurchase of common stock, including excise tax (in shares)   (686)          
Repurchase of common stock, including excise tax (164,924)     (164,924)      
Purchase of subsidiary shares from noncontrolling interest (1,453)   (48)       (1,405)
Contributions from noncontrolling interest 506           506
Other comprehensive income (loss) 56,281         56,281  
Net income 417,083     417,083      
Balance, end of period (in shares) at Dec. 31, 2023   57,787          
Balance, end of period at Dec. 31, 2023 3,471,470 $ 58 1,008,766 2,501,107 $ 0 (39,040) 579
Treasury stock, end of period (in shares) at Dec. 31, 2023         0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Restricted stock units vested (in shares)   381          
Equity withheld for employee taxes (in shares)   (122)          
Equity withheld for employee taxes (33,881)   (33,881)        
Stock issued in connection with 2021 acquisition (in shares)   13          
Stock issued in connection with 2021 acquisition 2,625   2,625        
Stock-based compensation expense $ 159,121   159,121        
Exercise of stock options (in shares) 483 483          
Exercise of stock options $ 22,554   22,554        
Issuance of common stock from employee stock purchase plan (in shares)   181          
Issuance of common stock from employee stock purchase plan 31,037   31,037        
Repurchase of common stock, including excise tax (in shares)   (1,854)          
Repurchase of common stock, including excise tax (399,845) $ (1)   (399,844)      
Noncontrolling interests acquired in business combination 1,358           1,358
Contributions from noncontrolling interest 7           7
Other comprehensive income (loss) (77,828)         (77,824) (4)
Net income $ 454,533     454,533      
Balance, end of period (in shares) at Dec. 31, 2024 56,869 56,869          
Balance, end of period at Dec. 31, 2024 $ 3,631,151 $ 57 1,190,222 2,555,796 $ 0 (116,864) 1,940
Treasury stock, end of period (in shares) at Dec. 31, 2024         0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Restricted stock units vested (in shares)   444          
Equity withheld for employee taxes (in shares)   (155)          
Equity withheld for employee taxes (28,227)   (28,227)        
Stock issued in connection with 2021 acquisition (in shares)   25          
Stock issued in connection with 2021 acquisition 4,375   4,375        
Stock-based compensation expense $ 169,508   169,508        
Exercise of stock options (in shares) 438 417          
Exercise of stock options $ 26,012   26,012        
Issuance of common stock from employee stock purchase plan (in shares)   213          
Issuance of common stock from employee stock purchase plan 28,533   28,533        
Repurchase of common stock, including excise tax (in shares)   (3,539)          
Repurchase of common stock, including excise tax (665,273) $ (3)   (665,270)      
Purchase of subsidiary shares from noncontrolling interest (1,358)           (1,358)
Other comprehensive income (loss) 135,409         135,409  
Net income $ 377,678     377,678      
Balance, end of period (in shares) at Dec. 31, 2025 54,274 54,274          
Balance, end of period at Dec. 31, 2025 $ 3,677,808 $ 54 $ 1,390,423 $ 2,268,204 $ 0 $ 18,545 $ 582
Treasury stock, end of period (in shares) at Dec. 31, 2025         0